The purpose of this research is to create an optimal strategy to convert the Japanese medical device industry into a highly competitive power in the field by analyzing its corporate activity. In this second report, we are analyzing the corporate activity of the Japan and U.S. Companies in the period from 1999 to 2003, the influence that the developed products give to profit and risk was studied. Multiple linear regression analysis was applied to 14 Japan and U.S. Companies of medical devices. In the first analysis, a dependent variable was the Operating Profit, Earnings before income taxes, and explanatory variables included : quantity of innovative products, high risk products and low risk products. In the second analysis, a dependent variable was number of recall of products, and explanatory variables included : number of innovative products, high risk products and low risk products. As a result of the first analysis, it was revealed that the number of innovative products give a positive correlation with the Operating Profit. As a result of the second analysis, it was revealed that the number of innovative products give a positive correlation with the number of recall of products. It was suggested by these two analytical results that the companies, where the strong safe security system coexists with high creation power of the innovative products, maintain a high competitive power. In addition, it is necessary to research the product development process to create the innovative products.